Technical Update - Novo Nordisk testing key support, down trend in the cards. Vestas Wind in down trend. DSV strong uptrend

Technical Update - Novo Nordisk testing key support, down trend in the cards. Vestas Wind in down trend. DSV strong uptrend

Equities 3 minutes to read
KCL
Kim Cramer Larsson

Technical Analyst, Saxo Bank Group

Summary:  Novo Nordisk is testing key support at 1,050. Close below can lead to heavy sell-off
Vestas Wind in downtrend short-term testing key support in medium-term range
DSV in strong uptrend both short- and medium-term
OMX C25 Index in down trend close to test key support


Novo Nordisk dipped yesterday below key strong support at around 1,050 for the fifth time only to bounce back and close above.
However, at the time of writing sellers are once again trying to push it below the support and this time they seems to be more succesful. 
Share price is below 21 and 55 daily Moving Averages which are both declining and below 100 Moving Average and RSI is showing negative sentiment after closing below the 40 threshold a few days ago, suggesting Novo is likely to trade lower.

If  Novo closes below 1,050 downtrend is confirmed 
If that scenario plays out a sell-off down to around 970-950 could be seen.

To resume uptrend a close above 1,113.60 is needed.

Source all charts and data: Saxo Group

Medium-term Novo has broken below upper rising trendline. RSI has been showing divergence at the peak indicating a weakening of the uptrend and a possible correction.
A daily closed below 1,050 could result in a larger correction to test the lower medium-term rising trendline

Vestas Wind is short-term in a confirmed downtrend trading in a steep falling channel like pattern.

Medium-term Vestas is close to breaking bearish out of sideways range. A weekly close below 173 combined with weekly RSI closing below 40 will confirm downtrend.
A down trend that could take Vestas to October 2022 levels around 131.

To establish a medium-term uptrend a close above 215.50 is needed.

DSV uptrend seems to be continuing. On both the daily and weekly charts RSI is showing positive sentiment with no divergence supporting the bullish trend that could take DSV higher. No strong resistance until around 1,527.

To demolish this bullish picture a close below 1,309 is needed.

OMX C25 Index
Novo is the biggest constituents in the OMX C25 Index and if Novo shares are tanking it will drag on the Index.
OMX C25 is in a short-term down trend. Key support at 1,759. A close below can lead to wide spread selling in C25 Indices.
However, Danish stocks and its Index are of course also influenced  by what is going on in the rest of the European Equity markets.
Across the board in Europe major Indices look heavy and are testing key support levels. See Technical Update on DAX, AEX25 and CAC40 here: Technical analysis DAX AEX25 BEL20 CAC40 in down trends  
Author us holding a position in DSV

Quarterly Outlook

01 /

  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992